ic 831423 has been researched along with fondaparinux in 3 studies
| Studies (ic 831423) | Trials (ic 831423) | Recent Studies (post-2010) (ic 831423) | Studies (fondaparinux) | Trials (fondaparinux) | Recent Studies (post-2010) (fondaparinux) |
|---|---|---|---|---|---|
| 44 | 0 | 5 | 1,190 | 112 | 559 |
| Protein | Taxonomy | ic 831423 (IC50) | fondaparinux (IC50) |
|---|---|---|---|
| Coagulation factor X | Homo sapiens (human) | 0.011 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Coghlan, DW; Gallus, AS | 1 |
| Bick, RL; Fareed, J; Frenkel, EP; Hoppensteadt, DA; Walenga, J | 1 |
| Luo, L; Wu, J; Wu, M; Wu, X; Xu, D; Zhang, L; Zhou, Z | 1 |
2 review(s) available for ic 831423 and fondaparinux
| Article | Year |
|---|---|
Heparin pentasaccharide.
Topics: Animals; Clinical Trials as Topic; Fondaparinux; Heparin; Humans; Oligosaccharides; Orthopedic Procedures; Polysaccharides; Thrombosis | 2002 |
Unfractionated heparin, low molecular weight heparins, and pentasaccharide: basic mechanism of actions, pharmacology, and clinical use.
Topics: Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Humans; Oligosaccharides; Pharmacokinetics; Polysaccharides; Thrombosis; Treatment Outcome | 2005 |
1 other study(ies) available for ic 831423 and fondaparinux
| Article | Year |
|---|---|
Chemical synthesis and pharmacological properties of heparin pentasaccharide analogues.
Topics: Animals; Anticoagulants; Fondaparinux; Heparin; Oligosaccharides; Polysaccharides; Rats | 2022 |